Clomifene
- Generic Name
- Clomifene
- Brand Names
- Clomid
- Drug Type
- Small Molecule
- Chemical Formula
- C26H28ClNO
- CAS Number
- 911-45-5
- Unique Ingredient Identifier
- 1HRS458QU2
- Background
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.
- Indication
Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.
- Associated Conditions
- Ovulatory Dysfunction
- Associated Therapies
- -
Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2017-06-23
- Lead Sponsor
- Navy General Hospital, Beijing
- Target Recruit Count
- 100
- Registration Number
- NCT02775877
- Locations
- 🇨🇳
Department of Obstetrics and Gynecology, Navy General Hospital., Beijing, Beijing, China
NAC in CC Resistant PCOS After LOD
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 144
- Registration Number
- NCT02775734
- Locations
- 🇪🇬
Ain Shams University Maternity Hospital, Cairo, Egypt
Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 42
- Registration Number
- NCT02710981
Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 210
- Registration Number
- NCT02690870
A Comparison of Letrozole and Clomifene Citrate
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 40
- Registration Number
- NCT02647424
- Locations
- 🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Woman's Health University Hospital, Egypt
- Target Recruit Count
- 88
- Registration Number
- NCT02644304
- Locations
- 🇪🇬
Assiut university, Assiut, Egypt
Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI
- First Posted Date
- 2015-12-23
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 86
- Registration Number
- NCT02638285
- Locations
- 🇮🇷
Health Policy Research Center, Shiraz, Fars, Iran, Islamic Republic of
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- mostafa gomaa hamid halawa
- Target Recruit Count
- 110
- Registration Number
- NCT02551367
Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Semnan University of Medical Sciences
- Target Recruit Count
- 388
- Registration Number
- NCT02523898
Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 600
- Registration Number
- NCT02479256
- Locations
- 🇪🇬
Ain Shams University Maternity Hospital, Cairo, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath